The Inadequacy of the Current Standard of Care for Glioblastoma

November 29, 2016
David A. Reardon, MD

David A. Reardon, MD, clinical director, center for neuro-oncology, Dana-Farber Cancer Institute, discusses the inadequacy of the current standard of care in glioblastoma (GBM).